Surmodics, Inc. (SRDX)
NASDAQ: SRDX · Real-Time Price · USD
29.31
-0.49 (-1.64%)
At close: Jun 6, 2025, 4:00 PM
29.40
+0.09 (0.31%)
After-hours: Jun 6, 2025, 5:32 PM EDT

Surmodics Statistics

Total Valuation

Surmodics has a market cap or net worth of $420.40 million. The enterprise value is $422.06 million.

Market Cap 420.40M
Enterprise Value 422.06M

Important Dates

The next estimated earnings date is Wednesday, July 30, 2025, before market open.

Earnings Date Jul 30, 2025
Ex-Dividend Date n/a

Share Statistics

Surmodics has 14.30 million shares outstanding. The number of shares has increased by 0.91% in one year.

Current Share Class 14.30M
Shares Outstanding 14.30M
Shares Change (YoY) +0.91%
Shares Change (QoQ) +0.33%
Owned by Insiders (%) 3.66%
Owned by Institutions (%) 79.37%
Float 12.99M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 3.44
Forward PS n/a
PB Ratio 3.81
P/TBV Ratio 9.24
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 3.47
EV / EBITDA 93.50
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.14, with a Debt / Equity ratio of 0.30.

Current Ratio 5.14
Quick Ratio 3.77
Debt / Equity 0.30
Debt / EBITDA 5.28
Debt / FCF n/a
Interest Coverage -1.14

Financial Efficiency

Return on equity (ROE) is -16.96% and return on invested capital (ROIC) is -1.65%.

Return on Equity (ROE) -16.96%
Return on Assets (ROA) -1.44%
Return on Invested Capital (ROIC) -1.65%
Return on Capital Employed (ROCE) -2.66%
Revenue Per Employee $312,532
Profits Per Employee -$51,062
Employee Count 389
Asset Turnover 0.70
Inventory Turnover 1.96

Taxes

In the past 12 months, Surmodics has paid $5.29 million in taxes.

Income Tax 5.29M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -30.20% in the last 52 weeks. The beta is 1.32, so Surmodics's price volatility has been higher than the market average.

Beta (5Y) 1.32
52-Week Price Change -30.20%
50-Day Moving Average 28.82
200-Day Moving Average 34.99
Relative Strength Index (RSI) 53.62
Average Volume (20 Days) 68,808

Short Selling Information

The latest short interest is 426,708, so 2.98% of the outstanding shares have been sold short.

Short Interest 426,708
Short Previous Month 476,507
Short % of Shares Out 2.98%
Short % of Float 3.29%
Short Ratio (days to cover) 6.17

Income Statement

In the last 12 months, Surmodics had revenue of $121.58 million and -$19.86 million in losses. Loss per share was -$1.40.

Revenue 121.58M
Gross Profit 90.78M
Operating Income -3.97M
Pretax Income -9.16M
Net Income -19.86M
EBITDA 4.51M
EBIT -3.97M
Loss Per Share -$1.40
Full Income Statement

Balance Sheet

The company has $31.15 million in cash and $32.81 million in debt, giving a net cash position of -$1.66 million or -$0.12 per share.

Cash & Cash Equivalents 31.15M
Total Debt 32.81M
Net Cash -1.66M
Net Cash Per Share -$0.12
Equity (Book Value) 110.25M
Book Value Per Share 7.71
Working Capital 57.80M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$5.32 million and capital expenditures -$2.12 million, giving a free cash flow of -$7.44 million.

Operating Cash Flow -5.32M
Capital Expenditures -2.12M
Free Cash Flow -7.44M
FCF Per Share -$0.52
Full Cash Flow Statement

Margins

Gross margin is 74.67%, with operating and profit margins of -3.27% and -16.34%.

Gross Margin 74.67%
Operating Margin -3.27%
Pretax Margin -11.99%
Profit Margin -16.34%
EBITDA Margin 3.71%
EBIT Margin -3.27%
FCF Margin n/a

Dividends & Yields

Surmodics does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.91%
Shareholder Yield -0.91%
Earnings Yield -4.72%
FCF Yield -1.77%

Analyst Forecast

The average price target for Surmodics is $43.00, which is 46.71% higher than the current price. The consensus rating is "Buy".

Price Target $43.00
Price Target Difference 46.71%
Analyst Consensus Buy
Analyst Count 3
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on December 7, 2000. It was a forward split with a ratio of 2:1.

Last Split Date Dec 7, 2000
Split Type Forward
Split Ratio 2:1

Scores

Surmodics has an Altman Z-Score of 7.62 and a Piotroski F-Score of 2.

Altman Z-Score 7.62
Piotroski F-Score 2